secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioCardia, Inc. (BCDA)
CIK:        0000925741
Form:       8-K
Filed at:   2026-02-03T23:59:59+00:00
Accession:  0001437749-26-002723
Event type: other
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioCardia announces acceptance of CardiAMP HF echocardiography data for late-breaking presentation at THT 2026
--------------------------------------------------------------------------------

- Echocardiography data from CardiAMP HF trial accepted for Late Breaking Clinical Trial Oral Presentation at THT Meeting.
- Presentation by Dr. Amish Raval, Professor of Medicine at UW School of Medicine and Public Health and CardiAMP HF National Co-PI.
- THT meeting takes place March 2-4, 2026 in Boston, MA.
- Title: 'Autologous Cell Therapy May Curb Pathological Ventricular Remodeling in Chronic Ischemic HFrEF Patients Selected for Favorable Cell Characteristics.'

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/925741/000143774926002723/0001437749-26-002723-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/925741/000143774926002723/bcda20260203_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-002723

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer